While the results have been disappointing and there was no significant effect on progression-free or overall patient survival, it is becoming clear that EGFR expression alone does not necessarily indicate tumor cell dependence on EGFR signaling and further molecular stratifications and patient selections are needed in future trials [63, 68, 69]. Here, EGFR is linked to neoplasm.